derivative phenethylamine hallucinogen acts highly potent full agonist human nbome compounds often associated lifethreatening toxicity studies nbome family compounds demonstrated substance exhibit neurotoxic cardiotoxic reports autonomic dysfunction remains prevalent nbome compounds individuals experiencing sympathomimetic toxicity vasoconstriction hypertension tachycardia addition symptoms toxidrome include agitation aggression seizure hyperthermia diaphoresis hypertonia rhabdomyolysis researchers report nbome intoxication frequently display signs serotonin likelihood seizure higher nbomes compared nbome nbohs regularly sold lsd blotter bitter taste different safety despite high potency recreational doses lsd produced low incidents acute fatalities involved nbome intoxication suggest significant number individuals ingested substance believed researchers report users familiar lsd may false sense security ingesting nbome fatalities due physical effects drug also reports death due selfharm suicide influence many nbome compounds high potency agonist activity additional receptors prolonged activation cause cardiac valvulopathy high doses chronic receptors strongly implicated causing druginduced valvular heart high affinity nbome compounds adrenergic receptor reported contribute stimulanttype cardiovascular vitro studies shown exhibit cytotoxicity neuronal cell lines compound potent methamphetamine reducing visibility respective cells neurotoxicity compound involves activation mapkerk cascade inhibition aktpkb signaling including derivative reduced visibility cardiomyocytes cells substances downregulated expression level kinase enzyme documented cardiac protective riksdag added narcotic drugs punishments act swedish schedule substances plant materials fungi normally medical use august published medical products agency mpa regulation lvfs listed substance class drug united kingdom result nbenzylphenethylamine catchall clause misuse drugs act stimulants phenylethanolamine